{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:29:32Z","timestamp":1767839372173,"version":"3.49.0"},"reference-count":0,"publisher":"CMA Impact Inc.","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAJ"],"published-print":{"date-parts":[[2020,6,29]]},"DOI":"10.1503\/cmaj.76023","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T09:27:43Z","timestamp":1593422863000},"page":"E728-E728","source":"Crossref","is-referenced-by-count":1,"title":["Renin\u2013angiotensin\u2013aldosterone system inhibitors to treat COVID-19?"],"prefix":"10.1503","volume":"192","author":[{"given":"Richard A.","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"382","published-online":{"date-parts":[[2020,6,28]]},"container-title":["Canadian Medical Association Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1503\/cmaj.76023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T15:15:26Z","timestamp":1651677326000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cmaj.ca\/lookup\/doi\/10.1503\/cmaj.76023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,28]]},"references-count":0,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2020,6,28]]},"published-print":{"date-parts":[[2020,6,29]]}},"alternative-id":["10.1503\/cmaj.76023"],"URL":"https:\/\/doi.org\/10.1503\/cmaj.76023","relation":{},"ISSN":["0820-3946","1488-2329"],"issn-type":[{"value":"0820-3946","type":"print"},{"value":"1488-2329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,28]]}}}